(no subject)

1 messages 1 people Latest: Feb 04, 2009

(no subject)

From: Serge Guzy Date: February 04, 2009 technical
Dear colleagues POP-PHARM is pleased to announce the release of the new version of the pdx-mc-pem program. The new program is free of charge and has as main add-in the MAP estimation procedure which usually improve considerably the efficiency of the MCPEM algorithm (pmethod=8 in SADAPT). My attempt was to create a user-friendly program that is suitable for most of the case studies you are usually dealing with. I had therefore to trade off between user-friendly and fully flexible environment. However the SADAPT program is there in case the PDX-MC-PEM is not appropriate as it provides both full flexibility and functionality. Population Mixture, Inter-occasion, covariate analysis, variance models can be accessed without any coding from the user part. Hundred of different built-in PK/PD models can be accessed easily (all standard PK models with and without non linear clearance, emax models and indirect response models) IN addition, user-defined models can be written and use a similar template as SADAPT. POP-PHARM is providing the following services 1: Free support for both SADAPT and PDX-MC-PEM installation and help with the step by step examples 2: POP-PHARM is providing to companies that are interested in house workshops that will cover usually the SADAPT program but if needed also the PDX-MC-PEM 3: Full support in the implementation of complex PK/PD models using either the PDX-MC-PEM or SADAPT program. POP-PHARM has partnered with different organizations that sponsor workshops (SADAPT) in the east coast. If people are interested to have a workshop given in the bay area (California) or anywhere else (in house or not), please let me know as it will be certainly possible. The following link gives you access to 1: PDX-MC-PEM program installation and step by step examples 2: SADAPT program installation and same step by step examples http://www.box.net/shared/static/n7ejo5ag3g.zip Best Regards; Serge guzy President,CEO; POP-PHARM; Inc. -- The information contained in this email message may contain confidential or legally privileged information and is intended solely for the use of the named recipient(s). No confidentiality or privilege is waived or lost by any transmission error. If the reader of this message is not the intended recipient, please immediately delete the e-mail and all copies of it from your system, destroy any hard copies of it and notify the sender either by telephone or return e-mail. Any direct or indirect use, disclosure, distribution, printing, or copying of any part of this message is prohibited. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorized to state them to be the views of XOMA.